Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia
Open Access
- 1 August 2009
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 13 (8a), 1513-1525
- https://doi.org/10.1111/j.1582-4934.2009.00798.x
Abstract
Toll-like receptor 4 (TLR4), a proximal signalling receptor in innate immune responses to lipopolysaccharide of gram-negative pathogens, is expressed in the heart. Accumulating evidence have consolidated the notion that TLR4 plays an essential role in the pathogenesis of cardiac dysfunction. However, the molecular mechanisms of TLR4 responsible for ischemia-induced cardiac dysfunction remain unclear. To address the signalling mechanisms of TLR4-deficiency cardioprotection against ischemic injury, in vivo regional ischemia was induced by occlusion of the left anterior descending coronary artery in wild-type (WT) C3H/HeN and TLR4-mutated C3H/HeJ mice. The results demonstrated that blunted ischemic activation of p38 mitogen-activated protein kinase and JNK signalling occurred in C3H/HeJ hearts versus C3H/HeN hearts, while ERK and AMP-activated protein kinase (AMPK) signalling pathways were augmented during ischemia in C3H/HeJ hearts versus C3H/HeN hearts. Intriguingly, ischemia-stimulated endoplasmic reticulum stress was higher in C3H/HeN hearts than that in C3H/HeJ as demonstrated by up-regulation of Grp78/BiP, Gadd153/CHOP and IRE-1alpha. Myocardial infarct, caspase-3 activity and terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining demonstrated that C3H/HeN hearts suffered more damage than those of C3H/HeJ hearts during ischemia. Moreover, isolated cardiomyocytes from C3H/HeJ hearts showed resistance to hypoxia-induced contractile dysfunction compared to those from C3H/HeN hearts, which are associated with greater hypoxic activation of AMPK and ERK signalling, better intracellular Ca(2+) handling in C3H/HeJ versus C3H/HeN cardiomyocytes. These findings suggest that the cardioprotective effects against ischemic injury of hearts with deficiency in TLR4 signalling may be mediated through modulating AMPK and ERK signalling pathway during ischemia.Keywords
This publication has 48 references indexed in Scilit:
- Deficiency of Insulin-Like Growth Factor 1 Reduces Sensitivity to Aging-Associated Cardiomyocyte DysfunctionRejuvenation Research, 2008
- Metallothionein alleviates glutathione depletion-induced oxidative cardiomyopathy in murine heartsCritical Care Medicine, 2008
- AMP-Activated Protein Kinase Conducts the Ischemic Stress Response OrchestraCirculation, 2008
- AMP‐ACTIVATED PROTEIN KINASE ACTIVATION AS A STRATEGY FOR PROTECTING VASCULAR ENDOTHELIAL FUNCTIONClinical and Experimental Pharmacology and Physiology, 2007
- Dissociation of AMP-activated protein kinase and p38 mitogen-activated protein kinase signaling in skeletal muscleBiochemical and Biophysical Research Communications, 2007
- Alterations in energy metabolism in cardiomyopathiesAnnals of Medicine, 2007
- AMP‐activated protein kinase – development of the energy sensor conceptThe Journal of Physiology, 2006
- Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarctionInternational Journal of Cardiology, 2006
- Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese miceJournal of Endocrinology, 2006
- Elevated gadd153/chop expression and enhanced c-Jun N-terminal protein kinase activation sensitizes aged cells to ER stressExperimental Gerontology, 2004